Lineage Cell Therapeutics, Inc. (LCTX)
1.70
+0.06
(+3.66%)
USD |
NYAM |
Apr 17, 16:00
1.69
-0.01
(-0.59%)
After-Hours: 20:00
Lineage Cell Therapeutics Shareholders Equity (Quarterly) : 44.55M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| SIGA Technologies, Inc. | 198.82M |
| Pacira Biosciences, Inc. | 693.11M |
| Niagen Bioscience, Inc. | 76.53M |
| Strata Critical Medical, Inc. | 279.07M |
| Prime Medicine, Inc. | 120.87M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 112.58M |
| Total Liabilities (Quarterly) | 69.24M |
| Debt to Equity Ratio | 0.0543 |
| Current Ratio | 5.204 |
| Net Debt Paydown Yield | 0.02% |